AdAlta Limited (ASX: 1AD) is an Australian public biotechnology company focused on the development and commercialisation of its i-body technology platform that has generated a pipeline of i-bodies (drugs), with an initial focus on treating fibrotic diseases. Our Corporate Fact Sheet provides an overview of the Company.
If you wish to receive further information about the company, please contact us.
AdAlta Ltd is happy to provide information about your shareholding.
Your information is held on a share registry, which can be found at https://automic.com.au.
As an investor you can obtain information on shareholdings and transactions by accessing the Automic website. Please contact the Automic Registry Service.
Phone (aus): 1300 288 664
Please contact Sam Cobb on +61 03 9479 5159 with further investment-related questions.
Further information can also be found at ASX.com.au.